The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1080/20565623.2024.2409054

The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis

Shu-Yi Dong & Bo Zou et al. · 2024

3Citations

Links

DOI

Journal

Unknown Journal

TL;DR

PSMD14 could serve as a potential biomarker of poor prognosis in cancers, including lung cancer, head and neck squamous cell carcinoma, ovarian cancer, breast cancer and hepatocellular carcinoma.

AI-generated by Semantic Scholar

Authors

Shu-Yi Dong, Shuxin Ding, Zhen Meng, Bo Zou